熱門資訊> 正文
埃森哲将以2.4亿美元现金收购Prosia
2026-10-13 20:14
- Agilent Technologies (A) on Tuesday said it has entered into a definitive agreement to acquire Proscia in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones.
- Proscia is an independent provider of enterprise digital pathology software.
- Proscia serves more than 4,000 laboratories, hospitals, and clinics, with trailing twelve months revenue exceeding $18 million, the company said.
- Agilent and Proscia entered into a multi-year distribution agreement in September 2022 to offer a comprehensive digital diagnostic-pathology system.
- Press release
More on Agilent Technologies
- Agilent Technologies, Inc. (A) Presents at U.S. All Stars Conference Transcript
- Agilent: The Recovery Is Real, But So Is The Valuation
- Agilent Technologies: Q3 Growth, Expanding Margins, And Raised Guidance
- Moderna, Illumina lead healthcare gains in September as medtech drags
- Agilent forecasts FY2026 revenue of $7.49B-$7.51B and EPS of $6.18-$6.21 as China returns to 9% growth
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。